高半胱氨酸增多症与动、静脉血栓形成

[1] A quantitative assessment of plasma homocysteine as a risk factorfor vascular disease. Boushey CJ,Beresford SAA,Omenn GS,et al. The Journal of The American Medical Association . 1995

[2] promotion ofvascular smooth muscle cell growth by homocysteine: alink to atherosclerosis. Tsai J,Perrella MA,Yoshizumi N,et al. Proceedings of the National Academy of Sciences of the United States of America . 1994

[3] Effects of vitamin B12, folate and vitamin B6 supplement in elderly peoplewith normal serum vitamin concentration. Naurath JH,Joosten E,Riezler R,et al. The Lancet . 1995

[4] Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Stefaro VD,Finazzi G,Mannucci PM. Blood . 1996

[5] Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis. Heijer MD,Blom HJ,Gerrits WBJ,et al. The Lancet . 1995

[6] Hyperhomocysteinemia as a risk factor for deep vein thrombosis. Heijer MD,Koster T,Blom HJ,et al. The New England Journal of Medicine . 1996

[7] seven novelmutations in the methy-lenetetrahydrofolate reductasegene and gene-type-phenotype correlations in severeme tyle ne tet ra hydrofolate reductase deficiency. Goyette P,Frosst P,Rosenslantt DS,et al. The American Journal of Human Genetics . 1995

[8] Homocysteine and arterial occlusive diseases. Malinov MR. Journal of Internal Medicine . 1994

[9] Homocysteine, athrombogenic agent, suppresses anticoagulant heparinsulfate expression in cultured porcine aortic endothelialcells. Nishinaga M,Ozawa T,Shimada K. The Journal of Clinical Investigation . 1993

[1] A quantitative assessment of plasma homocysteine as a risk factorfor vascular disease. Boushey CJ,Beresford SAA,Omenn GS,et al. The Journal of The American Medical Association . 1995

[2] promotion ofvascular smooth muscle cell growth by homocysteine: alink to atherosclerosis. Tsai J,Perrella MA,Yoshizumi N,et al. Proceedings of the National Academy of Sciences of the United States of America . 1994

[3] Effects of vitamin B12, folate and vitamin B6 supplement in elderly peoplewith normal serum vitamin concentration. Naurath JH,Joosten E,Riezler R,et al. The Lancet . 1995

[4] Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Stefaro VD,Finazzi G,Mannucci PM. Blood . 1996

[5] Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis. Heijer MD,Blom HJ,Gerrits WBJ,et al. The Lancet . 1995

[6] Hyperhomocysteinemia as a risk factor for deep vein thrombosis. Heijer MD,Koster T,Blom HJ,et al. The New England Journal of Medicine . 1996

[7] seven novelmutations in the methy-lenetetrahydrofolate reductasegene and gene-type-phenotype correlations in severeme tyle ne tet ra hydrofolate reductase deficiency. Goyette P,Frosst P,Rosenslantt DS,et al. The American Journal of Human Genetics . 1995

[8] Homocysteine and arterial occlusive diseases. Malinov MR. Journal of Internal Medicine . 1994

[9] Homocysteine, athrombogenic agent, suppresses anticoagulant heparinsulfate expression in cultured porcine aortic endothelialcells. Nishinaga M,Ozawa T,Shimada K. The Journal of Clinical Investigation . 1993